TM6SF2 is a transmembrane protein involved in the secretion of VLDL cholesterol, and subsequent studies have associated this SNP with a higher risk of advanced fibrosis in patients with NAFLD, independent of other risk factors [60,68,69]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.